In this Healio Video Perspective from the virtual Eyecelerator conference, Tom Mitro, president and chief operating officer at Aerie Pharmaceuticals, gives an update on the company’s products and pipeline.
The update includes a look at cooperation efforts with Santen to develop Rocklatan (netarsudil 0.02% and latanoprost ophthalmic solution 0.005%) in Asia.
Uncategorized